FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Collections Drugs and Devices, 1940-1963 ✖Remove constraint Collections: Drugs and Devices, 1940-1963 Titles 4122. Misbranding of dextro-amphetamine sulfate tablets and secobarbital sodium capsules. U. S. v. Clyde King (Clyde King Drug Co.), and Benjamin H. Darnell. Pleas of guilty. Fine of $50 against each defendant. ✖Remove constraint Titles: 4122. Misbranding of dextro-amphetamine sulfate tablets and secobarbital sodium capsules. U. S. v. Clyde King (Clyde King Drug Co.), and Benjamin H. Darnell. Pleas of guilty. Fine of $50 against each defendant. Defendants Clyde King, trading as the Clyde King Drug Co., Birmingham, Ala., and Benjamin H. Darnell, a pharmacist for the company. ✖Remove constraint Defendants: Clyde King, trading as the Clyde King Drug Co., Birmingham, Ala., and Benjamin H. Darnell, a pharmacist for the company. Adjudicating Courts Northern District of Alabama ✖Remove constraint Adjudicating Courts: Northern District of Alabama

Refine by:

  • 4122. Misbranding of dextro-amphetamine sulfate tablets and secobarbital sodium capsules. U. S. v. Clyde King (Clyde King Drug Co.), and Benjamin H. Darnell. Pleas of guilty. Fine of $50 against each defendant.1

  • Clyde King, trading as the Clyde King Drug Co., Birmingham, Ala., and Benjamin H. Darnell, a pharmacist for the company.1